ADVM-043

N/A

Report date: 2024/08/29 20:00:20

Base Information

Drug NameADVM-043
Drug Alias NameANN-001ADVM-043AAVrh-10hA1ATAAVrh.10hA1ATAAVrh.10halpha1AT
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAVrh10 vector
Mechanisms of ActionGene transferenceSerine protease inhibitors
TargetsSerine protease
Therapy Area/Indicationsalpha 1-Antitrypsin Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesWeill Cornell Medical College
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdverum Biotechnologies Inc
Active IndicationsN/A
Inactive Indicationsalpha 1-Antitrypsin Deficiency

Other Information

ATC CodeN/A
Related LinksN/A